Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary?
- PMID: 28420172
- PMCID: PMC5412432
- DOI: 10.3390/ijms18040848
Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary?
Abstract
Aldosterone producing adenoma and bilateral adrenal hyperplasia are the two most common subtypes of primary aldosteronism (PA) that require targeted and distinct therapeutic approaches: unilateral adrenalectomy or lifelong medical therapy with mineralocorticoid receptor antagonists. According to the 2016 Endocrine Society Guideline, adrenal venous sampling (AVS) is the gold standard test to distinguish between unilateral and bilateral aldosterone overproduction and therefore, to safely refer patients with PA to surgery. Despite significant advances in the optimization of the AVS procedure and the interpretation of hormonal data, a standardized protocol across centers is still lacking. Alternative methods are sought to either localize an aldosterone producing adenoma or to predict the presence of unilateral disease and thereby substantially reduce the number of patients with PA who proceed to AVS. In this review, we summarize the recent advances in subtyping PA for the diagnosis of unilateral and bilateral disease. We focus on the developments in the AVS procedure, the interpretation criteria, and comparisons of the performance of AVS with the alternative methods that are currently available.
Keywords: adrenal vein sampling; aldosterone; aldosterone producing adenoma; bilateral adrenal hyperplasia; cosyntropin stimulation; primary aldosteronism.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.J Clin Endocrinol Metab. 2001 Mar;86(3):1066-71. doi: 10.1210/jcem.86.3.7282. J Clin Endocrinol Metab. 2001. PMID: 11238487
-
Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary Aldosteronism.Hypertension. 2016 Jan;67(1):146-52. doi: 10.1161/HYPERTENSIONAHA.115.06305. Epub 2015 Nov 16. Hypertension. 2016. PMID: 26573704
-
Modification of the protocol for selective adrenal venous sampling results in both a significant increase in the accuracy and necessity of the procedure in the management of patients with primary hyperaldosteronism.Surgery. 2012 Oct;152(4):643-9; discussion 649-51. doi: 10.1016/j.surg.2012.07.007. Epub 2012 Aug 26. Surgery. 2012. PMID: 22929402
-
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis.Ann Endocrinol (Paris). 2016 Jul;77(3):208-13. doi: 10.1016/j.ando.2016.01.008. Epub 2016 Mar 29. Ann Endocrinol (Paris). 2016. PMID: 27036860
-
Primary aldosteronism: part II: subtype differentiation and treatment.J Nephrol. 2008 Jul-Aug;21(4):455-62. J Nephrol. 2008. PMID: 18651533 Review.
Cited by
-
Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.Endocrine. 2018 Dec;62(3):506-516. doi: 10.1007/s12020-018-1696-z. Epub 2018 Aug 2. Endocrine. 2018. PMID: 30073456 Review.
-
A comparison of the performance of 68Ga-Pentixafor PET/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism.Front Endocrinol (Lausanne). 2024 Feb 14;15:1291775. doi: 10.3389/fendo.2024.1291775. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38419957 Free PMC article.
-
The value of plasma metanephrine measurements during adrenal vein sampling.Endocr Connect. 2024 Jan 12;13(2):e230300. doi: 10.1530/EC-23-0300. Print 2024 Feb 1. Endocr Connect. 2024. PMID: 38055778 Free PMC article.
-
Diagnosis of primary aldosteronism in the hypertension specialist centers in Italy: a national survey.J Hum Hypertens. 2018 Nov;32(11):745-751. doi: 10.1038/s41371-018-0094-6. Epub 2018 Aug 6. J Hum Hypertens. 2018. PMID: 30082690
-
Radiological characteristics and diagnostic impact of duplicated right adrenal veins on adrenal venous sampling in primary aldosteronism.Diagn Interv Radiol. 2021 Nov;27(6):754-761. doi: 10.5152/dir.2021.21388. Diagn Interv Radiol. 2021. PMID: 34792030 Free PMC article.
References
-
- Käyser S.C., Dekkers T., Groenewoud H.J., van der Wilt G.J., Carel Bakx J., van der Wel M.C., Hermus A.R., Lenders J.W., Deinum J. Study heterogeneity and estimation of prevalence of primary aldosteronism: A systematic review and meta-regression analysis. J. Clin. Endocrinol. Metab. 2016;101:2826–2835. doi: 10.1210/jc.2016-1472. - DOI - PubMed
-
- Monticone S., Burrello J., Tizzani D., Bertello C., Viola A., Buffolo F., Gabetti L., Mengozzi G., Williams T.A., Rabbia F., Veglio F., Mulatero P. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J. Am. Coll. Cardiol. 2017;69:1811–1820. doi: 10.1016/j.jacc.2017.01.052. - DOI - PubMed
-
- Mulatero P., Tizzani D., Viola A., Bertello C., Monticone S., Mengozzi G., Schiavone D., Williams T.A., Einaudi S., La Grotta A., et al. Prevalence and characteristics of familial hyperaldosteronism: The PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms) Hypertension. 2011;58:797–803. doi: 10.1161/HYPERTENSIONAHA.111.175083. - DOI - PubMed
-
- Mulatero P., Monticone S., Bertello C., Viola A., Tizzani D., Iannaccone A., Crudo V., Burrello J., Milan A., Rabbia F., et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 2013;98:4826–4833. doi: 10.1210/jc.2013-2805. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical